Moreover, ginsenoside Re could promote insulin secretion, stimulate cannabinoid type 1 receptor (CB1) and CaMKK β to activate the AMPK signaling pathway, inhibit insulin resistance induced by TNF-α, and improve blood glucose uptake and diabetic nephropathy, so as to exert the goal of anti-diabetic. This evidence concerns the gene CNR1 and diabetic kidney disease.